Stay updated on Nivolumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Advanced NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe study record for the nivolumab trial in advanced non-small cell lung cancer is displayed, including its completed status, eligibility criteria, treatment arms, locations, and outcome measures.SummaryDifference100%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedExtensive content including locations, study documents, and sponsor-related links was removed from the page, reducing access to participating sites and protocol materials. A minor Revision tag was added.SummaryDifference19%

Stay in the know with updates to Nivolumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced NSCLC Clinical Trial page.